Lineage Cell Therapeutics, Inc.
Status: Publicly traded
Direct answer
Lineage Cell Therapeutics, Inc. is publicly traded on AMEX under the ticker LCTX.
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; and OPC1, an allogeneic...
Can you invest in Lineage Cell Therapeutics, Inc.?
Yes. Lineage Cell Therapeutics, Inc. trades publicly on AMEX as LCTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lineage Cell Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.